Vaso (VASO) Stock Price, News & Analysis

Company Overview

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Key Stats

• Today's Range: $0.13 to $0.14
• 50-Day Range: $0.11 to $0.15
• 52-Week Range: $0.11 to $0.32
• Volume: 97,168 shs
• Average Volume: 75,603 shs
• Market Capitalization: $22.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Vaso Stock Analysis - MarketRank™

Vaso scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Vaso.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Vaso has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.02% of the outstanding shares of Vaso have been sold short.

Short Interest Ratio / Days to Cover

Vaso has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vaso has recently decreased by 25.04%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Vaso does not currently pay a dividend.

Dividend Growth

Vaso does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.02% of the outstanding shares of Vaso have been sold short.

Short Interest Ratio / Days to Cover

Vaso has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vaso has recently decreased by 25.04%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: N/A

News Sentiment

Vaso has a news sentiment score of -0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Vaso insiders have not sold or bought any company stock.

Percentage Held by Insiders

44.50% of the stock of Vaso is held by insiders. A high percentage of insider ownership can be a sign of company health.

VASO Stock Analysis - Frequently Asked Questions

How have VASO shares performed this year?

Vaso's stock was trading at $0.1199 at the beginning of 2025. Since then, VASO shares have increased by 6.5% and is now trading at $0.1277.
View the best growth stocks for 2025 here.

How were Vaso's earnings last quarter?

Vaso Co. (OTCMKTS:VASO) announced its earnings results on Wednesday, August, 14th. The company reported $0.00 earnings per share for the quarter. The company earned $17.54 million during the quarter. Vaso had a negative trailing twelve-month return on equity of 0.45% and a negative net margin of 0.14%.

How do I buy shares of Vaso?

Shares of VASO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vaso own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaso investors own include Aramark (ARMK), AutoZone (AZO), Bank of America (BAC), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Intel (INTC) and Kimco Realty (KIM).

Company Calendar

• Last Earnings: 8/14/2019
• Today: 2/22/2025
• Next Earnings (Estimated): 3/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:VASO
• CUSIP: N/A
• CIK: 839087
• Web: www.vasocorporation.com
• Phone: 516-997-4600
• Fax: 516-997-2299
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $4.80 million
• Net Margins: -0.14%
• Pretax Margin: 0.42%
• Return on Equity: -0.45%
• Return on Assets: -0.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.42
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $81.02 million
• Price / Sales: 0.28
• Cash Flow: $0.03 per share
• Price / Cash Flow: 4.29
• Book Value: $0.14 per share
• Price / Book: 0.91

Miscellaneous

• Outstanding Shares: 175,700,000
• Free Float: 97,512,000
• Market Cap: $22.44 million
• Optionable: Not Optionable
• Beta: 2.16